APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 51 filers reported holding APREA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $40 | – | 118 | -40.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 198 | -95.3% | 0.00% | – |
| Q1 2022 | $8,000 | – | 4,183 | +2887.9% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 140 | -98.6% | 0.00% | – |
| Q3 2021 | $53,000 | +96.3% | 10,306 | +83.5% | 0.00% | – |
| Q2 2021 | $27,000 | -41.3% | 5,616 | -37.6% | 0.00% | – |
| Q1 2021 | $46,000 | +206.7% | 9,004 | +210.1% | 0.00% | – |
| Q4 2020 | $15,000 | -99.3% | 2,904 | -96.6% | 0.00% | – |
| Q3 2020 | $2,070,000 | +2.3% | 86,046 | +64.9% | 0.00% | – |
| Q2 2020 | $2,024,000 | +9.5% | 52,178 | -1.9% | 0.00% | – |
| Q1 2020 | $1,848,000 | +3596.0% | 53,171 | +4716.2% | 0.00% | – |
| Q4 2019 | $50,000 | – | 1,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |